Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.


Phase N/A Results

Summary of Purpose

Specific aim: To test the effects of nasal expiratory positive airway pressure (EPAP) therapy on sleep apnea severity among patients with recent ischemic stroke. Hypothesis 1: Ischemic stroke patients with sleep apnea will have less severe sleep apnea, as measured by the apnea-hypopnea index (AHI), with nasal EPAP therapy compared with a control night. Hypothesis 2: Ischemic stroke patients will have...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 August 2016.

1 Nov 2012 5 Oct 2012 1 Apr 2015 1 Apr 2015 1 Aug 2016 19 May 2016
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Crossover Assignment